Assessing the Combination of Durvalumab (MEDI4736) and Trabectedin in Solid Tumors
about
Assessing the Combination of Durvalumab (MEDI4736) and Trabectedin in Solid Tumors
description
clinical trial
@en
klinisch onderzoek
@nl
name
Assessing the Combination of Durvalumab (MEDI4736) and Trabectedin in Solid Tumors
@en
type
label
Assessing the Combination of Durvalumab (MEDI4736) and Trabectedin in Solid Tumors
@en
prefLabel
Assessing the Combination of Durvalumab (MEDI4736) and Trabectedin in Solid Tumors
@en
P1476
A Phase I Study Assessing the ...... nd Trabectedin in Solid Tumors
@en
P3098
NCT03496519
P580
2018-10-01T00:00:00Z
P582
2021-10-31T00:00:00Z